Title : Bortezomib induces different apoptotic rates in B-CLL cells according to IgVH and BCL-6 mutations.

Pub. Date : 2006 Nov

PMID : 17134969






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bortezomib (Btz), is a proteasome inhibitor, currently undergoing clinical trials whose function, at least in part, by stabilizing the IkappaBalpha protein and inhibiting NFkappaB activation. Bortezomib NFKB inhibitor alpha Homo sapiens
2 Bortezomib (Btz), is a proteasome inhibitor, currently undergoing clinical trials whose function, at least in part, by stabilizing the IkappaBalpha protein and inhibiting NFkappaB activation. Bortezomib NFKB inhibitor alpha Homo sapiens